Illinois Tool Works Inc (ITW) 2025 Q4 法說會逐字稿

Good morning. My name is Regina and I will be your conference operator today. At this time, I would like to welcome everyone to the ITW's fourth-quarter and full-year earnings conference call. (Operator Instructions) Thank you.

Erin Linnihan, Vice President of Investor Relations, you may begin the conference.

Thank you, Regina. Good morning and welcome to our ITW fourth-quarter 2025 conference call. I'm joined by our President and CEO, Chris O'Herlihy; and Senior Vice President and CFO, Michael Larsen.

During today's call, we will discuss ITW's fourth-quarter and full-year 2025 financial results and provide guidance for full-year 2026. Slide 2 is a reminder that this presentation contains forward-looking statements. Please refer to the company's 2024 Form 10-K and subsequent reports filed with the SEC for more detail about important risks that could cause actual results to differ materially from our expectations. This presentation uses certain non-GAAP measures, and a reconciliation of those measures to the most directly comparable GAAP measures is contained in the press release.

Please turn to slide 3, and it's now my pleasure to turn the call over to our President and CEO, Chris O'Herlihy. Chris?

Thank you, Erin. Good morning, everyone. As you saw on our press release morning, ITW delivered a solid finish to the year. In the fourth quarter, we outperformed our underlying end markets with revenue growth of more than 4% and delivered a 7% increase in GAAP EPS to $2.72. Through disciplined operational execution, we expanded operating income and margins to record levels.

Starting with the top line. Organic growth of 1.3% marked our best quality performance of the year. Overall Q4 demand improved as reflected in higher-than-normal sequential improvement of 4% from Q3. In addition to market outperformance, the ITW team continued to execute at a high level resulting in operating income of $1.1 billion, an increase of 5%. Segment margins were 27.7%, up 120 basis points, with 140-basis-point contribution from enterprise initiatives.

Looking back on a challenging external environment in 2025, the ITW team delivered another year of robust financial performance. We consistently outperformed our markets, solidly improved profitability, and made meaningful progress on our next phase key strategic priorities.

Throughout the year, we remained laser focused on building above-market organic growth fueled by Customer-Back Innovation or CBI into a defining ITW strength. We are pleased to have achieved 2.4% CBI fuel revenue growth in 2025, a 40-basis-point improvement, as we track toward our 2030 goal of 3% plus. Furthermore, I'm encouraged by a key leading indicator of CBI contribution, our patent filings, which increased by 9% last year, following an 18% increase in 2024.

Turning to guidance, we entered 2026 with solid momentum. Per our usual approach, our organic growth projection of 1% to 3% reflects current demand levels adjusted for seasonality. We are well-positioned to capitalize on any further improvement in the macro environment. Our EPS guidance midpoint of $11.20 represents 7% growth, and we expect operating marginal expansion of about 100 basis points powered by enterprise initiatives. Our 2026 forecast ensures we remain firmly on track to deliver on our 2030 performance goals.

In closing, I want to sincerely thank our global ITW colleagues for their unwavering dedication to serving our customers and executing our strategy with excellence each and every day.

With that, I'll turn the call over to Michael to provide more detail on the quarter and our guidance for 2026. Michael?

Thank you, Chris. Good morning, everyone. In Q4, the ITW team delivered a solid operational and financial finish to the year. Organic growth was 1.3%, foreign currency translation added 2.5%, and acquisitions contributed 0.3%, bringing total revenue growth to 4.1%. Notably, our 4% sequential revenue growth from Q3 to Q4 significantly outperformed our historical sequential average of 2%.

On a geographic basis, North America grew about 2%, Asia Pacific was up 3%, while Europe declined 2%. On the bottom line, we achieved the fourth quarter record operating margin of 26.5% with enterprise initiatives contributing 140 basis points.

As noted in our press release, segment operating margin was 27.7%, 120-basis-point increase, with incremental margins of more than 50%. All seven segments expanded operating margins driven by enterprise initiatives which contributed between 80 and 210 basis points per segment.

Free cash flow conversion to net income was 109% for the quarter. We repurchased $375 million of shares and our tax rate was 22.8%.

Please turn to slide 4 and as Chris mentioned, CBI is our most impactful driver for organic growth. We're pleased with our 2025 progress reaching a 2.4% CBI contribution, a 40-basis-point year-over-year improvement. We expect meaningful progress again in 2026 on this key strategic initiative as we track toward our longer-term goal.

Now let's move to the fourth quarter segment results, starting with Automotive OEM where revenue increased 6% and organic revenue increased 2%. On a regional basis, North America was up 2%, while Europe was down 1%, and China grew 5%. For the full-year 2025, this segment outperformed relevant builds, and we expect our typical 200 to 300 basis points of outperformance in 2026.

Full-year margins are a prime example of ITW's Do What We Say execution. In 2025, margins improved by 150 basis points to 21.1%, consistent with the goal established during our 2023 Investor Day. Driven by our culture of continuous improvement, we expect to further expand these margins in 2026.

Turning to slide 5, Food Equipment delivered revenue growth of 4%, with organic growth of 1%, as equipment was flat, offset by 3% growth in service. By region, North America was flat with institutional end markets up in the high single-digits, offset by restaurants down also in the high single-digits. Retail was a bright spot of nearly 5%, and the international business grew 2%, with Europe up 2%.

Test & Measurement and Electronics had a solid quarter. Revenue up 6% and organic revenue up 2%. Test & Measurement was up 3% and Electronics was flat against the tough comparison year over year. Notably, we began to see a positive pick-up in semiconductor and electronics activity with our semi-related businesses up mid-single-digits in the quarter. Operating margins improved by 110 basis points to 28.1%.

Moving on to slide 6, Welding revenue grew 3% with organic growth of 2% in the fourth quarter. Equipment was up 4% and while consumables were flat, filler metals were up in the high single-digits. Regionally, North America was up 4%, while international declined 5% against the tough comparison of 9% last year. Notably, operating margin reached 33.3%, a 210 basis points improvement.

Polymers & Fluids had a strong top line quarter with 5% organic growth supported by new product launches in automotive aftermarket which grew 5%. Polymers was up 4% and Fluids grew 6%. On a geographic basis, North America was up 5% and international grew 4%. Operating margin expanded 110 basis points to 29%.

Turning to slide 7. In Construction Products, organic growth was down 4%. Regionally, North America was down 4% with residential renovation down 5%, while commercial construction was up 5%. Europe was down 5%, and Australia and New Zealand was flat. Despite the top line challenge, the team successfully expanded margins by 100 basis points to 29%.

Specialty Products, revenue increased 4% and organic revenue was up 1%. Equipment growth was particularly strong up 12% and consumables were down 2% in the quarter. North America was flat and international grew 3%.

Moving to side 8 and full-year 2025 results. Our global teams continue to execute at a high level, enabling us to consistently outperform our end markets and expand margins to deliver solid financial results in a mixed macro environment.

Throughout 2025, we maintained our focus on maximizing ITW's growth and performance over the long term as we invested close to $800 million in high-return internal projects to accelerate organic growth and sustain productivity in our highly profitable core businesses. At the same, we increased our dividend for the 62nd consecutive year, and we returned a total of $3.3 billion to shareholders.

Moving to slide 9 and our guidance for full-year 2026. ITW is well-positioned to deliver meaningful progress on both the top and bottom lines in 2026. Per our usual process, our total revenue projection of 2% to 4% and organic growth projection of 1% to 3% is based on current levels of demand adjusted for typical seasonality. At ITW, growth is high-quality, meaning it is delivered at attractive incremental margins in the mid to high 40s for 2026.

In terms of overall profitability, we expect operating margin to improve by approximately 100 basis points, to a range of 26.5% to 27.5%. This includes 100 basis points contribution from our enterprise initiatives which provides margin expansion that is largely independent of volume. We're projecting a GAAP EPS range of $11.00 to $11.40, representing 7% growth at the $11.20 midpoint.

Regarding the cadence for the year, we expect the first-half/second-half EPS split of approximately 47% and 53% consistent with 2025. Factoring in typical seasonality, Q1 EPS should contribute roughly 23% of the full year total. Lastly, we expect free cash flow conversion to net income of greater than 100% and plan to buy back approximately $1.5 billion of our shares in 2026.

Turning to our final slide, slide 10. All seven segments are projecting high-quality organic growth based on current run rates adjusted for seasonality. And every segment is well-positioned to outperform its respective end markets again in 2026. Consistent with ITW's continuous improvement, never-satisfied mindset, all segments are also projecting margin improvement supported by another year of solid contributions from our enterprise initiatives.

In summary, all seven segments are heading into 2026 well-positioned to deliver solid organic growth with industry-leading profitability and incremental margins.

With that, Erin, I'll turn it back to you.

Thank you, Michael. Regina, I think we're ready to open the queue for questions, please.

(Operator Instructions)

Andy Kaplowitz, Citigroup.

Good morning, everyone. Chris and Michael, so Test & Measurement within the segment looks like it did improve meaningfully in Q4. You called out the commentary on semicon. It's been improving for you again, which is good to hear. You've had a couple of maybe, I'll call it, head fakes on semicon so you're seeing a more definitive turn now and are you seeing a bit more of an unlock of your CapEx businesses, in general, in terms of growth?

Yeah. Again, in general, as you said, Test & Measurement had a pretty solid quarter after what was a pretty challenging year. You might remember middle of the year, we had pretty much a CapEx freeze related to the the China shipments for two quarters. And so we certainly saw an improvement in bookings in general industrial here in Q4. As Michael mentioned, we also saw an improvement in demand for semi-electronics and used the context that semi is about 15% of Test & Measurement, just to give you a perspective.

I would say that the semi, at this point, seems sustainable based on what we see right now. But as you said, we had an uptick in Q2, came back down in Q3, but we've seen a recovery in Q4. And I think this is a part of the market where we have very strong competitive advantages, particularly as it relates to semi manufacturing and testing equipment. So whatever happens, we're particularly well-positioned to take share as the end market continues to improve in semi.

Yeah. Maybe just to add beyond that, Andy, the general industrial orders are also improving in Test & Measurement, as well as you've seen the improvement in revenues and our growth rates on the equipment side in Welding. So all of that suggests that we are certainly seeing, I would say, a little bit more than green shoots at this point and meaningful improvement not just in sales but also orders. And backlog is looking pretty good at this point. And so we got some pretty good momentum going into 2026 as reflected in the guidance that we gave for those two segments.

Yeah. That's great to hear, guys. And then when we think about margin expansion across your businesses in '26, I know you expected in all segments. Normally, I would think we just model higher incrementals where you're modeling higher growth. But you, for instance, had really good margin performance in Construction again in Q4. And there is metals inflation out there. So any more advice on how to think about margin performance across the segments?

Yeah. I would just say -- I'll go back to our prepared remarks there, Andy, we expect, based on bottoms-up planning with our segments, based on having a chance to review the enterprise initiative savings, the actual projects for 2026, we expect every segment to improve their operating margins in 2026. And the biggest driver, as I think you pointed out, will be the enterprise initiatives again. So about 100 basis points from initiatives.

And then, also, there is some positive operating leverage at incremental margins that, at this point, are quite a bit higher than what we put up historically, as I said, in that mid to high 40s. So maybe that's a way to think about the margin improvement for each one of the segments in 2026.

Now I will say this, we do have three segments now that are above 30%. And so maybe you'll see a little bit less of improvement in those segments relative to the ones like Auto that have been putting up some meaningful operating margin improvement. Test & Measurement as well that still have a ways to go to get to Test & Measurement to that high 20%, 30% level.

An improved CBI is the other driver of increased margins. Yeah. As you know, as we've talked about, the CBI progress is really encouraging, obviously, not just as a contributor to growth, but all of these new products that are coming in are coming in at higher margins. And so that's really the key to unlocking margin improvement on a go-forward basis, particularly in places like Automotive OEM.

Appreciate all the color, guys. Thank you.

Joe Ritchie, Goldman Sachs.

Good morning. Can we touch on the price/cost dynamics? Thinking in the slides, you had mentioned that price/cost is expected to be positive in 2026. Can you elaborate on that a little bit? And then also, seeing that resin prices have continued to come down, at this point, what percentage of your COGS is resin?

Well, let me start with the first part. I think on price/cost, we've been talking about this for a while in terms of this having normalized after the wave of tariff-related increases we saw last year. So at this point, we're back to where we used to be on price/cost which is slightly favorable for full-year 2026. But not a big driver of the margin improvement. Really, the efforts, particularly the tariffs, have really been centered around not just price but also supply chain, and making sure we do everything we can to mitigate some of these increases, so we don't have to pass them on to our customers. So that's maybe one way to think about price/cost.

I'm not sure I have the resin number right in front of me. It's pretty small. I think here, again, I'm not quite sure where you were going with the question, but to the extent that there are increases or decreases in resin cost, those will be reflected in the pricing actions that are taking, again, at the division level where this is more of a meaningful driver of their material costs.

Yeah. I appreciate the comments, Michael. I guess, I was thinking back in the, I'll call it, 2016 time frame when you guys saw some deflation in resin. And I remember it being like 10% to 15% of your COGS back then. Obviously, that's a long time ago. But there were areas like poly, fluid, areas in auto, injection molding, gas caps, plastic fasteners where you guys did see it benefit. So I was just really trying to think back at that time frame where you had some deflation in your cost structure, but then you have these longer-term contracts and the Auto business where you can get some pricing. And so I was just trying to understand whether that was going to be potentially a meaningful mover to the 2026 bridge.

Yeah. Joe, as I said, the longer-term contract dynamic is still there, but the percentage is considerably less than and I think it was 10% to 15% back then, I would say.

Yeah. And we have a very small portion of our business in Specialty Products that indexed to resin cost. In Automotive, they're typically aren't adjustments made on the way up or on the way down, as you're well aware. So not something that's on our radar here in a meaningful way just because it's not going to be material to the overall performance of the company this year as we sit here today.

Okay. Great. Thank you. I'll get back in the queue. Appreciate it.

Julian Mitchell, Barclays.

Good morning. Maybe just wondered, first off, if you could flesh out any sense of seasonality for this year? Anything unusual or untoward? And maybe remind us what we should expect typically for the first quarter, please?

Sure, Julian. I'd say there's really nothing unusual going on this year. We expect the year to unfold in line with typical seasonality. It looks a lot like last year in terms of the quarterly splits. We kind of laid out the first-half/second-half EPS split, 47/53. That's what we did last year. As you know, Q1 always starts out down a few points of sequential revenue drop from Q4 to Q1, like last year, that's about $100 million in revenue from Q4 '25 to Q1 '26. Margins also dropped a little bit in Q1. And we typically end up around 23% of the full-year EPS here in the first quarter. And then in Q2, we see a pick-up again in margins from Q1 to Q2, revenues picked back up again.

And every quarter this year, if you model this on a run rate basis, you'll see pretty meaningful revenue growth on a year-over-year basis in line with the guidance that we're giving and that 2% to 4% revenue growth. Every quarter is projected to have margin improvement on a year-over-year basis including in Q1 -- maybe a little bit more modest than Q1. And then it picks up as we go through the year in Q2, Q3, and Q4. Earnings per share grows in line with the guidance range we're giving you here which is 7% of the midpoint.

And so that's kind of how we typically play that out. Free cash flow tends to improve as we go through the year. So that's maybe as much as I can give you here.

That's extremely helpful. Thank you, Michael. And maybe my follow-up, just to understand, you talked about CBI, I think, 2.4% contribution to sales in 2025, and that was 40 bps better than the prior year. Maybe sort of flesh out a little bit the progress there in 2026. What we should expect? And any thoughts on the Product Line Simplification side? Thank you.

Yeah. So on CBI, as you mentioned, Julian, strong momentum here in '25, encouraged by the progress that we're making across the company and particularly encouraged, I think, by the increased strength of our pipeline of new products. And it's really one of the reasons, we believe, we're outperforming in our end markets.

A lot of successful products launches this year across the company, I would say, most particularly in Welding, Test & Measurement, Food Equipment, Automotive. Good progress, 40 basis points of improvement in 2025. With continued incremental improvement here in 2026, well on the path to get to 3%-plus by 2030.

Particularly encouraged, I think, by patent filings. I mean patent filings were up 18% in 2024, up another 9% in 2025. And why that's particularly important is because at ITW, this is a really leading indicator of progress on CBI where our patent filings are more often than not protecting customer solutions. And so an increase in patent activity is often pretty well-correlated with future revenue growth. So really encouraged by everything we're seeing. More progress in 2026.

It can be a bit lumpy, you can get ups and downs on this. But the trajectory is certainly on its way up. And we're very, very confident at this point that the 3%-plus target is well within our reach.

And I would not make it -- I think PLS is, to me, a different kind of a conversation. I don't really see a correlation between them. The only overlap between PLS and CBI is that they're both focused on differentiation. PLS is about ensuring that we (inaudible) prune around differentiation and CBI, of course, is pursuing differentiation in a product development context.

But PLS, for us, in '26, we see as more of a maintenance level, 30 to 50 basis points, that's lower than 2025. But it's very much a bottom-up number. It's really decided on at the divisional level. As we said before, it's a fundamental part of the 80/20 front-to-back and the ongoing strategic review portfolio pruning that goes on in our divisions. And we have, obviously, a very highly developed methodology around this.

But we get a lot of benefits from PLS implementation. We do it, we get benefit in terms of growth from the standpoint of strategic clarity, ensuring that we're executing on our most important customers and products, and then effectively deploying resources on the back of that.

And then, of course, from a margin improvement standpoint, the cost savings from PLS are a meaningful contributor to the enterprise initiatives that we generate every year. A lot of these projects will have a pay back of less than a year.

So I think I would not really connect them that much. They're both very active in the company. PLS a little lower this year. But full steam ahead on CBI.

Yeah. In terms of PLS, a little bit lower year over year; and CBI contribution to revenue a little bit higher on a year-over-year basis. So that's what's supporting the top line guidance that we're giving you today.

Scott Davis, Melius Research.

Good morning, guys. Congrats on turning the corner here on the top line. The buyback is great, but I have to ask, because you didn't mention M&A at all on the prepared remarks, is that off the table for '26 or you didn't mention it just because it's more opportunistic?

It's the latter, Scott. It's certainly on the table for the right companies. As we've often said, we're focused on high-quality acquisitions that really will extend our long-term growth potential, why we've been able to leverage the business model to improved margins. And we review opportunities all the time on an ongoing basis. We're pretty selective given that we genuinely believe we have a pretty compelling organic growth opportunity.

But we're also pretty active in terms of reviewing opportunities and to the extent that we find the right opportunities, while acknowledging, I think, the challenging valuation trends that we're seeing right now, then we will be appropriately aggressive in pursuing them.

We obviously did the MTS deal three or four years ago. It turned out to be a great acquisition, met all of our criteria. Similarly, in the quarter just past, we had won bolt-on acquisition in the semi-manufacturing space, which is all the high-quality growth attributes that we look for. And we're certainly very open to doing more deals like this. And I would say, we're actively prospecting around these deals, but we got to find them, and when we find them, we will do it.

Yeah. I would just add, I agree with what Chris said, I think it's not necessarily an easy time to be a disciplined acquirer and often, the challenge is really around valuation. And we're not going to do deals that don't make sense to ITW which means we're not going to do deals where we can't generate a reasonable risk-adjusted rate of return for our shareholders. So that's been our long-term positioning here and that part of it is not going to change on a go-forward basis.

And we agree with you that the buyback is a great way to allocate surplus capital to our shareholders. Also contributes, frankly, $0.20 a share or 2% EPS growth on an annual basis. And so that will remain an active share repurchase program and will remain an important part of our capital allocations strategy on a go-forward basis.

That's a good answer. Guys, I don't want to beat a dead horse, the CBI stuff is pretty interesting, what does it take to get to 3%? Is it spending more or getting more out of what you have? And the reason why I ask that question is that up 18% and even up 9% patents there, that's a pretty big growth. Do you have to spend more to get to that 3%? What's the gaining factor of bridging that gap?

Yeah. It's not spending more, Scott. I think we've been meaningfully investing in a very focused way for a number of years to build up the muscle around this. And really, what's moving the needle is very much the similar approach to what we took on 80/20 front-to-back 10 years ago. And we saw the results that accrued from that. But really, it's about a much higher level of leadership, time, and focus. And certainly, continuing to invest and build capabilities as we had been doing for the last four or five years.

And on that basis, we've seen innovation contribution more than double over the last five years. The capability, that build that we're doing is at the segment level, but also in our divisions. We have lots of great innovation practice around the company. And as we've mentioned on prior calls, we really codified this into a very effective and holistic innovation framework. And we launched that framework in the second half of 2024. Again, this is the exact approach that we took in 80/20 front-toback.

So all that's certainly taken root. We see it in the patent filings. We see it in the yield. We're well on track here to do the 3%-plus. But I think all the pieces are in place, and it's now a question of just building momentum and ensuring we get that consistently high-quality of practice in every part of the country. And that will get us to more than 3%, for sure.

Yeah. And I might just add that we've added the CBI metric as one of the key elements in our incentive plans on a go-forward basis. So if you look at the long-term incentive plans here at ITW, in addition to margins, returns, EPS growth, we've added -- or the Board has added CBI yield just in alignment with the overall strategic importance of this metric and this initiative on a go-forward basis.

Interesting. Thank you, guys. Best of luck this year. I'll pass it on.

Tami Zakaria, J.P. Morgan.

Good morning. Thank you so much. So the Auto segment growth in China was, I think, about 5%. I think granted builds were also slower in the fourth quarter in China. But anything else to call out there and how are you thinking about growth in Auto in China as you look into 2026?

Yeah. So we see strong growth in China around 2026, largely on the basis of the satisfactory work that we've done on really penetrating the EV space. Electric vehicles for us are very much a source of innovation and growth, what we're seeing from our customers. We've been generally leveraging that EV growth through new product innovation. We made significant investments over the last number of years, targeting and building up our presence in EV.

China represents about 65% of world-wide EV builds, and we're growing very nicely there with a very strong position with Chinese OEMs which is now over 70% of the market. So we're really well-positioned. We see the growth in China in Auto is being very sustainable, really on the back of the work we've done on EV, in particular, around CBI related to EV.

I might just add, China has been a great growth story for ITW over the years driven primarily by the Auto OEM business which, as you said, grew 5% in Q4, about 12% for the full year. And the expectation remains the same in terms of outgrowing builds in China, fueled by CBI and (inaudible) growth with the Chinese OEMs, as Chris said. So we'd expect growth in China Auto OEM in that mid to high single-digits.

I'd just make a comment. Overall, on China, up 9% for the full year. Again, strong growth in China in the Auto business. But also, Test & Measurement up high single-digits. Welding up mid-teens. And so the expectation for this year, '26, is that China, which is now about $1.2 billion and 8% of our revenues, will grow in the mid, maybe even in the high single-digits based on what we're seeing for 2026.

And I might just add lastly that margins in China, as you know, are the same as everywhere else around the world and as Chris said, we'll continue to invest in China and repatriate cash efficiently to the US as we've done over many years.

That is fantastic to hear. Thank you. And staying on the same topic, thanks for all the color around China. How are you thinking about growth in the US or Americas versus Europe as it relates to the 1% to 3% organic growth outlook for the year?

Yeah. I think one of the things that was certainly encouraging here in the fourth quarter was the organic growth rate in North America up 2%-plus. And we expect about the same, maybe a little bit better than that, based on run rates in 2026. Europe certainly a little bit more challenging. We don't expect much improvement in Europe. And then, Asia Pacific was up 6% last year, primarily China. And we expect, like you said, another kind of meaningful contribution from Asia Pacific and China in the mid single-digit range.

North America, really, I'd say, pretty encouraging. Europe stays about the same. And Asia Pacific, up in the mid-single-digits. China up in the mid, maybe high single-digits. And so that's how you get to that 1% to 3% organic growth. And like we said earlier, again, more contribution from CBI, less of a headwind to top line from PLS, and you get to that 1% to 3% organic, 2% to 4% revenue, for the full year.

Great. Thank you.

Jamie Cook, Truist Securities.

Good morning. Two questions, I guess just my first one, the sequential revenue growth in the quarter, the 4% relative to normally, 2%. Just color around that. Do you think that's more ITW-specific, i.e. CBI is getting more traction or would you say it's probably more just industrial markets getting better with PMI readings starting to get better, above 50, last month?

And then, my second question, Michael, just on the incremental margins for 2026, obviously implied very strong, you said, mid to high 40s. That's above your 35% to 40% medium term target on okay-organic growth. So I'm just wondering if there's an underappreciated margin story or incremental margins can be structurally higher, maybe it's CBI, but just trying to piece that above-average incremental margins versus your target on 1.5% organic growth, I don't know, it just seems better than what I always thought. Thank you.

Yeah. Pretty good, right? Let me talk about incrementals, but I'm glad you asked, by the way. I think historically, we've been in that 35% to 40% range. That's what our long-term TSR algorithm, it's based on 35% to 40%. If you look at what we've been putting up over the last few quarters with limited growth, frankly, starting to improve; and when we look at the plan for 2026, that's where we get to the mid to high 40s.

We can't really think of a reason why this wouldn't be sustainable over the long-term. I mean, we've done a lot of work around the portfolio; over a decade of enterprise initiatives; the margin profile, variable margin, gross margin, all of those things, the quality of the portfolio has never been better than it is today. And then you add on top of that accelerating contribution from new products that all are coming in at higher margins.

And then maybe most importantly, as Chris said and I mentioned in my remarks, we are doing all of this while we are investing in ITW to kind of maximize the long-term performance from a growth and profitability standpoint. So about $800 million this year in our organic growth initiatives, in our productivity initiatives, the enterprise initiatives.

And so it's not like we're holding back on investments. All of this is happening -- these incrementals in the mid to high 40s are happening while we're fully funding all the quality projects that we have available to us inside the the company. So I think that's -- Anything (inaudible)?

Yeah. I agree with everything Michael said. I would just highlight, Jamie, this is one of the side benefits of PLS. You do PLS for enough time, what happens is you get improvement in the quality of the portfolio. PLS is effectively a portfolio pruning exercise. And so what's really driving these incrementals and the reason that we fundamentally believe there are no sustainability in the mid-40s comes from improvement in the quality of our portfolio from many years of thoughtful PLS, coupled with a continuous improvement in the practice of the business model against that portfolio.

So you got those two things working together, and that's ultimately why these incrementals have now shifted from what was mid-30s to what we now believe in the mid-40s.

Right. And then I think, Jamie, on your other question on the sequentials from Q3 to Q4, it was pretty broad-based, nothing really stood out which suggests that this is really maybe a little bit of tailwind from the markets after a long time, years of headwinds. It was more pronounced in the segments that have a higher contribution from CBI. That is true.

We didn't talk about Polymers & Fluids. But high contribution from new products in the Automotive aftermarket. But also in the Fluids business, the part of that business that's really centered aronud biopharma. And then in the performance polymer side, it was growth in China, again, taking advantage of the EV growth that Chris talked about earlier.

Test & Measurement, also seeing a pickup here sequentially from Q3 to Q4. They typically do. Maybe a little bit more pronounced than usual, and I think that's part of the semi pick-up that we talked about. We saw that start to come through, not just in order activity, but also an actual sales here in the fourth quarter. So it feels pretty good. Good momentum going into 2026, and off to a pretty good start, so far.

Thank you.

Steven Fisher, UBS.

Thanks. Good morning. If I take out the 100 basis points of enterprise initiatives, it seems like the margins are maybe really only flattish. I'm curious why they wouldn't be higher with the positive organic growth and the high incrementals you're talking about. Maybe the incrementals are a function of the enterprise initiatives. But why isn't the margins higher with that positive organic growth?

Yeah. That's a good question, Steven. First, let me just say, it's hard to quibble with margins, I think, that are in that 26% to 27% range to begin with. But if you look at 2026, there's definitely some positive operating leverage given the midpoint of our revenue guidance here, that 3% range, 2% organic. We're getting about 100 basis points from the enterprise initiatives price/cost, it's slightly favorable.

And then what you're seeing is an offset which is primarily inflation in some of our employee-related costs. So these are wages, health and welfare benefits. And there's also some investment that Chris talked about to really accelerate the organic growth rate inside the company and maintain high levels of productivity inside the company. So those are really -- we've talked about this category before and so that's the offset to what we're giving you.

And I might just say, we're giving you a range of margins, right? So 26.5% to 27.5%, about 100 basis points of improvement. And if a short-cycle demand recovery really materializes and we get organic growth rates moving up in our range here at the incrementals, we're talking about, you're absolutely right, we should expect to see higher margins in 2026.

Super helpful. And then just maybe a clarification. Did I hear you say that commercial side of Construction in North America was up in the quarter? And I guess, if so, how surprised were you to see that? Were you already seeing that in your run rates at the start of the quarter? Or is that something that changed? And are you seeing that carry forward? I mean you do have a pretty big inflection in Construction in '26.

Yeah. I'd say it's a fairly small portion of our business. Look at North America, about 20% of our sales are into the commercial side of things. They can be a little bit lumpy. There was some pick-up in activity, as you might expect, related to things like data centers, for example, which sounds very exciting. But keep in mind what I just said, this is a pretty small part of the company. But certainly encouraging to see a pickup on the commercial side.

While the residential side, perhaps our most interest-rate sensitive business, remains really stuck in some pretty challenging end markets. Housing starts down in the mid-single-digits. But perhaps, 2026 could be the year this really turns around on the residential side. That's not included in our guidance, but if it were to happen, we would be really well-positioned to take advantage of that.

Yeah. The improvement drivers for '26 are more related to less PLS and more CBI.

Okay. Perfect. Thank you.

Sabrina Abrams, Bank of America.

Good morning, everyone. I wanted to follow up on something that I believe you said in response to Julian's question. If every quarter we have revenue growing 2% to 4%, I think the FX tailwind, just based on the (inaudible), FX tailwind is pretty material in Q1 and then it tails off quite a bit in the remaining quarters of the year. So would it be fair to think that the organic portion of growth accelerates as we move through the year? Just trying to think if that assumption is correct and what's underlying the assumption. Thank you.

Yeah. I think that's definitely, as you pointed out, a little bit more currency tailwind here in the first quarter. There is positive organic growth in Q1, but it's not as high as it is in Q2, Q3, and Q4. So maybe that's a way to think about it.

Thank you. And then, I don't think anyone asked on this segment, but Polymers & Fluids had a nice surprise to the upside, at least, relative to what I was modeling. And it seems that it was pretty broad-based across the auto aftermarket and the fluids and polymer side. Anything to call out there that you're seeing from an end market demand standpoint that may be trended differently versus expectation? And it seems that the guide for 1% to 3% next year would be quite conservative given the run rate, what we saw in Q4, so just any color there would be great. Thank you.

Yeah. We did actually talk about this a couplo of minutes ago, but just real quick. A big contribution from CBI new products in the automotive aftermarket, specifically in the care care business. If you're on the market for wiper blades. Rain-X wiper blades were up meaningfully here in the fourth quarter with the launch of a new wiper blade in that space.

In China, specifically, Polymers, continues to gain share on the automotive EV side of things, up double digits, more than 10% in the fourth quarter. And then, the reagents business that's part of Fluids, which is really focused around biopharma, was up more than 20%. And again, what you're seeing is more CBI, a little less PLS. And we're expecting more of the same here as we go into 2026.

Got it. I guess just as a quick follow-up then, just want to understand why guiding for deceleration from Q4 next year?

Well, I'm not sure that's really the case, I mean, I think we're guiding 1% to 3%. If you look at the performance for the full year this year in Polymers & Fluids, it was a little bit different than the fourth quarter. And then, obviously, we're not going to launch the same amount of new products every quarter. So maybe the fourth quarter was a little bit higher from a CBI standpoint than the typical run rate. So maybe that's a way to think about it.

Thank you.

David Raso, Evercore.

Hi. I wonder if you'd help us. We're all sort of dancing around the organic cadence. How is January playing out versus the 1% to 3% guide? It just feels like there's a lot of -- filler metals up high single-digit, semis up mid single. it feels like you're off to a relatively strong start to the year based off those cyclical trends exiting or am I misreading the first quarter organic is at the full-year guide or even above? Any color in January would be great.

And the company inventory, it went down a little bit sequentially -- I mean, it moves around a lot, I appreciate that, but it went down to where -- it wasn't even up year over year more than sales. And to me, that could be a little tell of, hey, we think things are picking up you'd be building some inventory. So just trying to square all that together. Thank you.

Yeah. Thanks, David. I think just on the inventory, that's kind of the typical cadence inventory levels. Inventories do come down towards the year end. I can tell you, there's nothing going on in terms of lowering inventory levels because we expect lower growth. I think, as a matter of fact, if you go back to the middle of the year, in some cases like Test & Measurement that Chris talked about with some of the tariffs, to mitigate the risk from a supply chain standpoint, we actually added inventory in a few segments to mitigate that risk. So nothing unusual really from an inventory standpoint in the fourth quarter.

I think January is off to where, I can say, we're right on track to where we thought we were going to be. I did say that the revenue growth guide for this year, if you look at it on a quarterly basis, we will be up if things stay the way are and obviously, it's a pretty dynamic environment in that 3% to 4% range.

The organic growth rate is slightly lower in the first quarter relative to Q2, Q3, Q4. That's typical seasonality based on what we know today. So it's not going to be 3%, 4% organic growth in the first quarter based on current run rates, but it will be positive organic growth.

We have a little bit more tailwind from currency at the beginning of the year, just how the comparisons work out. And so that's how you get to a revenue growth rate in Q1 that's maybe closer to the other quarters even though organic is lower. Does that make sense to you?

Yeah. That's helpful. And semi, I know you said 15% of the business, I think it used to be a little bit bigger but obviously, it's been slower. That incremental margin I feel, historically, when that starts moving, the incrementals, to be fair, the T&M margins were better than I was modeling for the quarter. Is semi a big part of that incremental margin improvement or am I overstating the impact --

No. That is correct. I mean the positioning has always been -- we know this is a cyclical space. And when we are at the bottom of the cycle, we want to be very profitable. And when things are going well, orders are picking up, revenues are picking up, the incrementals come through at above-average levels and above- average levels of profitability. So that's a reasonable assumption.

Now, it's 15% of Test & Measurement. It's 3% of ITW. But it is a space, as you know, when these cycles start to pick up, you can see some really above-average meaningful growth rates for a period of time. It's too early to tell whether that's what's going on here. But if you look at fab utilization, you look at the order activity, you look at plus-5% attractive margins of Q4, it's looking pretty promising as we just start 2026.

One month in, I'll just caution, things can change quickly in this environment. But we feel really good about where we're at. We feel confident in our guidance and well-positioned to deliver some solid results here, both operationally and financially in 2026.

All right. Thank you for the time. Appreciate it.

And that concludes our question-and-answer session and our call today. Thank you all for joining. You may disconnect at this time.